https://pbs.twimg.com/media/GBQbkNJXkAAntNw.jpg
INVIGORATE-1 Study: IV Secukinumab for Treatment of Active axSpA Dr. Atul Deodhar reports on abstract 2545 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/Fhv7dhDTJA https://t.co/Zz0PwFjOD4

Links:

INVIGORATE-1 Study: IV Secukinumab for Treatment of Active axSpA | RheumNow https://bit.ly/3RGXjEO
Dr. John Cush
RheumNow
13-12-2023
×